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Introduction
UNICEF estimates that there are nearly 2.2 billion children 
and young people under 18 years of age, accounting 
for more than a third of the world’s population.1 The UN 
Convention on the Rights of the Child requires that state 
parties take ‘appropriate measures’ to protect this age group 
from the illicit use of drugs. However, the ‘war on drugs’ often 
trumps young people’s rights.2,3 This chapter will provide a 
global snapshot of the harms experienced via injecting drug 
use (IDU) among young people aged under 18 and existing 
harm reduction responses targeted at this population. 
Alcohol, cannabis and ‘club drug’ use remain much more 
prevalent than IDU among this population. However, this 
chapter focuses specifically on youth injecting, which 
continues to represent a significant blind-spot in terms of 
research and public health responses. The chapter begins 
by outlining recent trends in IDU among young people. As 
part of the Global State of Harm Reduction 2012 survey, 
new international data were collected from civil society 
and researchers, and this chapter reports our analyses 
of these data to provide a unique and timely study of 
legal age restrictions and other barriers to young people 
accessing harm reduction services. This chapter also 
highlights case studies of best practice for meeting the 
needs of this population in different settings, to inform our 
recommendations for improving policies and services to 
reduce drug-related harm.
Young people who inject drugs: 
prevalence and harms
Although overall levels of youth drug use appear to be 
stabilising or decreasing in many high-income countries4,5,6  
surveys of the general population conceal the drug-related 
harms experienced by the most vulnerable groups of young 
people. This includes young people who are not in education 
and street-involved youth – populations whose drug use is 
less likely to be transitory and more likely to progress onto 
more problematic patterns of use, such as IDU.7 The impact 
of current economic recessions is likely to further increase 
the vulnerability of young people,8 and record levels of child 
poverty and youth unemployment have already led some 
commentators to describe a new ‘lost generation’ of young 
people devoid of jobs and hope. 9
Furthermore, drug use is a universal and globalising 
phenomenon. Young people in Western Europe and North 
America represent a small fraction of the total global youth 
population: more than four-fifths of the world’s children and 
young people aged 18 years and younger live in low- and 
middle-income countries in Eastern Europe, Asia, Africa 
and South America. Recent reports have drawn attention 
to a ‘historic high’ in youth drug use globally,10 and IDU has 
spread to new regions. For example, the Pangaea Global 
AIDS Foundation estimates that there are now over 25,000 
people who inject drugs (PWID) in Tanzania, and that over 
40% of this population is living with HIV.11 HIV transmission 
via unsafe injecting in sub-Saharan Africa is a relatively new 
phenomenon, and young people are likely to be among the 
most vulnerable.12
While IDU still only represents a small proportion of drug 
use reported by under-18s overall, in many regions of the 
world the age of initiation of injecting now appears to be 
decreasing.13 Those young PWID who are sharing injecting 
equipment can transmit blood-borne viruses including 
HIV and Hepatitis C. These youth are also at greater risk of 
other preventable diseases such as tuberculosis. Research 
consistently shows that young injectors are more likely 
than older ones to report sharing equipment with other 
injectors and less likely to access needle and syringe 
exchange services.14,15  Young people also often have a lack of 
knowledge and misconceptions about HIV transmission.16
According to UNICEF in 2011,16 globally young people 
account for 2,500 new HIV infections every day. Failures to 
meet targets on reducing HIV transmission among young 
people is in a large part due to unsafe injecting practices 
and the criminalisation of these behaviours. It is estimated 
that in countries such as Belarus, China, Italy, Poland, Spain 
and Russia more than half of HIV infections are due to unsafe 
injecting,17 much of this among youth. More generally, 
young people are also often the first to experiment with new 
substances, and are often highly connected to dense drug-
supply networks, making them highly susceptible to new 
drug-related harms. 
Young people who inject drugs: 
current responses and data gaps
Despite increasing global coverage of harm reduction 
services,18,19 there remains a lack of youth-focused harm 
reduction services, and a potential gap between the age 
of initiation of injecting and the age at which services are 
accessible to young people. Current responses remain 
dominated by prevention and punishment discourses. 
In some regions, strict age restrictions on access to these 
services have been highlighted as a major barrier, as young 
people are denied access to evidence-based interventions 
such as needle and syringe exchange programmes (NSPs) 
and opioid substitution therapy (OST). Criminal laws 
increase that risk and other barriers to young people 
accessing harm reduction services have also been identified, 
including appointment-based service provision and a lack 
of youth-work expertise and training among practitioners.20 
Furthermore, youth participation in the design of policies 
and programmes remains rare. 
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However, to date, there have been no attempts to map out 
and synthesise these barriers globally. The Global State 2012 
data collection questionnaire offers a novel lens through 
which to study age restrictions and other barriers to NSP and 
OST access among the youth population. Data were collected 
by surveying civil society organisations and key researchers 
working in the harm reduction field around the world to 
explore region-by-region developments in harm reduction 
since the previous Global State report was released in 2010. 
In the 2012 survey, specific questions were asked for the first 
time about the barriers to young people accessing services 
and legal age restrictions in different countries and regions 
(for more information see the Introduction to this report). 
Data on young people were available from all the Global 
State regions except for the Middle East and North Africa, 
which is, therefore, not included in these analyses.
Harm reduction services for young 
people: a global snapshot
Overall, of 85 countries reporting at least one NSP or OST 
site, data on the existence of age restrictions were available 
for 77 countries. Of those countries that reported data on 
age restrictions, 18 countries reported an age restriction for 
accessing NSPs, and 29 for accessing OST. Most commonly 
the age restriction was 18 years, but in some cases it was 
much higher (e.g. Georgia, Norway and Sweden). Even in 
countries with no legal age restrictions, the application of 
other requirements, such as compulsory parental consent 
or evidence of previous failed attempts at detoxification or 
other drug treatment modalities, and ‘aiding and abetting’ 
laws limit access to harm reduction services for young 
people. Table 1 provides more information on the existence 
of age restrictions by country, and the survey responses have 
also been synthesised in narrative form and are presented, 
region-by-region.a
a  Please see section 2: Regional Overviews for a comprehensive list of countries 
considered as part of each of the world regions. 
Country/territory with at 
least one reported NSP 
or OST site
Legal age restriction for 
accessing NSP  
(age in brackets)
Legal age restriction for 
accessing OST services 
 (age in brackets)
ASIA
Afghanistan Data n/a No
Bangladesh Data n/a Yes (18)
Cambodia No Yes (18) 
China Yes (18) No 
Hong Kong No NSP No 
India Yes (18) Yes (18)
Indonesia Data n/a Yes (18)
Macau No No
Malaysia No No 
Maldives No NSP No
Mongolia Data n/a No OST
Myanmar No No 
Nepal No Yes (18)
Pakistan Yes (18) No OST
Philipinnes Data n/a No OST
Taiwan Data n/a Data n/a
Thailand No No 
Vietnam Yes (18) Yes (18)
LATIN AMERICA
Argentina No No OST
Brasil No No OST
Colombia No NSP No
Mexico No No
Paraguay No No OST
Uruguay No No OST
CARIBBEAN
Puerto Rico No No
SUB-SAHARAN AFRICA
Kenya Data n/a Data n/a
Mauritius Yes (18) Yes (18)
Nigeria No NSP Data n/a
Senegal No NSP Data n/a
South Africa Yes (18) Data n/a
Tanzania No No
EURASIA
Albania No No
Armenia No Data n/a
Azerbaijan Data n/a Yes (18)
Belarus No Yes (18)
Bosnia  and 
Herzegovina
No No 
Bulgaria No Yes (18)
Croatia No No
Czech Republic Yes (15) Yes (15)
Estonia Yes (18) No
Georgia No Yes (21)
Hungary No Yes (18)
Kazakhstan No Data n/a
Kosovo No No 
Kyrgyzstan No No
Latvia Data n/a Data n/a
Lithuania Yes (18) Yes (18) 
Macedonia Yes (18) Yes (16)
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Country/territory with at 
least one reported NSP 
or OST site
Legal age restriction for 
accessing NSP  
(age in brackets)
Legal age restriction for 
accessing OST services 
 (age in brackets)
Moldova Data n/a Yes (18)
Montenegro Data n/a Data n/a
Poland No No
Romania Yes (18) Yes (16) 
Russia No No OST
Serbia Yes (15) Yes (15)
Slovakia No Yes (18)
Slovenia No Yes (16) 
Tajikistan No No
Turkmenistan Data n/a No OST
Ukraine Yes (14) Yes (14)
Uzbekistan Data n/a No OST
WESTERN EUROPE
Austria Data n/a Data n/a
Belgium No Yes (18)
Cyprus No No 
Denmark No No
Finland No No
France Yes (18) Yes (15)
Germany Yes (18) Yes (18) 
Greece Data n/a Data n/a
Iceland No NSP Data n/a
Ireland No No
Italy No No 
Luxembourg Data n/a Data n/a
Malta Data n/a Data n/a
Netherlands No No
Norway Data n/a Yes (25)
Portugal No Yes (18)
Spain Yes (18) Yes (18)
Sweden Yes (20) Yes (20)
Switzerland No No
Turkey No NSP Data n/a
United Kingdom No No
OCEANIA
Australia No No
New Zealand Yes (16) No 
NORTH AMERICA
Canada No No 
United States No Yes (18) 
Asia
Despite a scale-up in services overall in the last two years, 
it was reported that harm reduction services in Asia almost 
always target male, adult PWID. A major barrier to service 
provision targeted at youth in the region appears to be their 
relative invisibility as a drug-using population. Few or no 
data are collected on this population in most countries in 
the region at present. Young people are, therefore, rarely a 
focus for intervention, and the vast majority of programmes 
lack any clear strategy for reaching and engaging under-18s. 
Even in Bangladesh, which has relatively high levels of NSP 
coverage in South Asia according to recent reviews,19,21 there 
are no data on, or provision for, younger PWID. Furthermore, 
many young injectors in Asia are using methamphetamine 
and pharmaceutical drugs (e.g. benzodiazepines), and their 
needs will not be addressed through OST.22
Legal age restrictions are also a barrier in the region. For 
example, in Nepal and Pakistan harm reduction projects can 
only work with those aged 18 and above, despite Article 33 of 
the UN Convention on the Rights of the Child requiring that 
state parties take ‘appropriate measures’ to protect under-
18s from drug-related harms. This is of particular concern in 
Pakistan, where the age of initiation into drug injecting is 
decreasing, according to a recent rapid assessment exercise.23 
Meanwhile, in China and Vietnam, despite an expansion of 
harm reduction service provision overall, age restrictions 
prevent under-18s from accessing these new services.
It was reported that legal age limits are a common reason 
for refusal by services, as they provide an objective way 
of rationing limited supply in the region. Stigma was also 
reported to be a major barrier, and many young PWID in 
the region deny they are dependent on drugs and need 
harm reduction services. At present, there is a mandate 
to disclose one’s identity, and service-users often have to 
effectively ‘register’ with authorities, as is the case in China. 
This is a clear impediment to accessing OST services and 
may disproportionately affect younger people. Furthermore, 
most OST clinics have yet to be integrated into general 
health services, with the consequence that those accessing 
treatment can easily be identified and stigmatised. 
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bLatin America 
Sporadic and isolated efforts largely characterise the 
development of harm reduction services in Latin America 
at present. Similar to Asia, a lack of harm reduction services 
for young people under 18 was reported in this region. 
Youth-focused approaches to reducing the harms associated 
with IDU are rarely an acceptable public health strategy in 
either South or Central American countries, and national 
drugs policies do not support this approach. Harm reduction 
responses which do emerge are normally led by NGOs, 
and it was reported that even where these do exist stigma, 
discrimination and criminalisation pose significant barriers to 
service use, especially for young people.
Despite these barriers, new examples of youth-focused harm 
reduction projects were reported. For example, in Rio de 
Janeiro a project was established in 2010 in an area known 
as ‘crack land’ where young people gather to use drugs. Work 
so far has focused on sensitising the health care system to 
the needs of these young PWID, including the development 
of a new course to train health workers, and the provision 
of syringes, pipes, lip balms and condoms. This project was 
supported by the federal government, the National Health 
Ministry, the Secretariat of State for Rio de Janeiro, the 
Federal University of Rio and the UN Office on Drugs and 
Crime. Also, in Mexico, the state authorities now buy and 
b   The ‘Opening Doors’ project has developed a toolkit on enhancing youth-friendly 
harm reduction, available at: http://ndarc.med.unsw.edu.au/resource/opening-doors-
enhancing-youth-friendly-harm-reduction-toolkit. 
distribute syringes through centres for youth integration 
and in some CAPASITS (state provider of HIV, AIDS and STI 
services) sites.
Sub-Saharan Africa
Even more so than in Asia and Latin America, Africa is 
a region characterised by a paucity of both data on the 
number of young PWID and harm reduction services for this 
group. In East Africa, there are major concerns at present 
of both increasing IDU in general and also earlier initiation, 
with reports of young people as young as 11 in Kenya 
and as young as six in Tanzania injecting drugs.26 Harm 
reduction services that target young people in East Africa, 
particularly in the coastal areas where IDU is concentrated 
(e.g. Mombasa, Dar es Salaam and Zanzibar) are urgently 
needed. Such services must also meet the needs of young 
women who are injecting drugs, who are subject to multiple 
vulnerabilities.27 Although there is no official data on the 
prevalence of IDU and service provision for young people, 
anecdotal information from some parts of West Africa 
suggests a rapid rise in IDU among youth and a severe harm 
reduction service provision gap.28 As HIV infection through 
IDU increases in sub-Saharan Africa, young people are a 
particularly vulnerable population.12 
The ‘Opening Doors’ project: increasing access to 
youth-friendly harm reduction in Asiab
‘Opening Doors’ is a response to current legislation across 
Asia which mostly prohibits access to harm reduction 
services for young people, as well as the stigmatising and 
punitive nature of current treatment approaches which 
exacerbate social exclusion. The project is funded by Aids 
Fonds, a Dutch NGO, and is a partnership between Access 
Quality International and the National Drug and Alcohol 
Research Centre, University of New South Wales, Australia.
Where community options do exist, young people have 
tended not to engage with these adult-oriented services. 
Informed by the World Health Organization’s model of 
‘youth-friendly health services’,24 the primary aim of the 
project is to increase access to harm reduction services for 
young PWID and those who are at risk of initiating IDU. The 
target age group is 10–25, with special attention paid to 
the engagement of difficult-to-reach young people. The 
project has been implemented in three sites so far: Bangkok, 
Thailand; Kunming, China; and Kathmandu, Nepal. 
In all three sites, participatory focus group research with 
young PWID has been used to identify local needs, engage 
them in service design and increase access to locally 
appropriate harm reduction services. For example, in 
Kunming, the main drug of concern remains heroin, with 
significant unmet needs identified following consultation 
with young people. The project site in Kunming has aimed 
to increase participation in ‘youth-friendly’ methadone 
maintenance therapy (MMT), alongside other activities such 
as counselling groups, employment assistance, visits and 
recreation.25 
An evaluation undertaken by Youth Vision in Nepal in 2010 
suggested that there had been a significant increase in the 
engagement of young people with harm reduction services 
after adopting the ‘Opening Doors’ approach. Young people 
accessing the services also reported improved mental 
health, less involvement with crime, a reduction in sharing 
of injection equipment and increased condom use. The 
projects have helped to establish new partnerships between 
the health, education, vocational training and employment 
sectors, building greater capacity for youth-focused harm 
reduction interventions in the region in the long term. 
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Eurasia
Many countries in Eastern Europe report high HIV prevalence 
rates among young people through the sharing of injecting 
equipment and unsafe sexual practices.29 Some positive 
legislative changes which aim to improve harm reduction 
services for young people were reported in this region. For 
example, in Serbia a new law allows juveniles aged 15 and 
over to have exclusive privacy over their medical records and 
consent rights regarding their health issues, which means 
no parental consent will be required to access NSP and 
OST. There are now no legal age restrictions for accessing 
NSP in Albania, Bosnia and Herzegovina, Bulgaria, Croatia, 
Hungary, Kosovo, Slovakia or Slovenia. However, since NSPs 
are often anonymous and client ages unrecorded, it is hard 
to assess whether PWID under 18 are being reached by these 
services.30
In other countries in the region, age restrictions remain a 
barrier to accessing harm reduction services. The Czech 
Republic and Macedonia both have legal age limits for NSPs, 
allowing only PWID who are at least 15 and 18 years old, 
respectively, to access sterile injecting equipment. Access 
to OST is also often subject to strict age regulations. For 
example, in Bulgaria and Hungary the minimum age for 
participation in OST is 18, and it is 21 in Georgia. The written 
consent of a legal representative or a parent of a minor is 
required prior to starting OST in Bosnia and Herzegovina, 
Romania and Kosovo, which also poses a significant obstacle. 
Additional barriers to service access in the region include 
stigma, fear of the police, and a lack of funding. NSPs are also 
rarely, if ever, tailored to young people’s needs. There are also 
a lack of youth-focused OST programmes, and to become 
eligible in many countries young people have to prove they 
were not successful in previous detoxification treatment.
Western Europe
The prevalence of injecting heroin and other drugs remains 
rare among young people in this region – typically only 
being reported by 1–2% or less of young people in general 
population surveys – while alcohol and cannabis remain the 
primary drugs used by young people.5,6 The incidence of 
new cases of HIV among PWID is also low in Western Europe, 
although incidence is still relatively high in some countries 
(e.g. Portugal), and recent increases have been observed 
in others such as Sweden.30 Furthermore, the burden of 
morbidity associated with IDU is not evenly distributed: 
certain groups of vulnerable young people are most at risk 
of transmission of HIV or Hepatitis C and other drug-related 
harms due to social and structural factors such as poverty 
and social exclusion.8 
There is a mixed picture in terms of the application of age 
restrictions to accessing harm reduction services in Western 
Europe (see Table 1). For example, legal age restrictions 
were reported to limit access to evidence-based harm 
reduction services for vulnerable young people in Belgium, 
Germany, Norway, Portugal and Sweden. Alternatively, in 
countries such as the UK, specialist services to safeguard 
children and young people from harm were reported to have 
been developed, and ‘minors’ are not excluded from NSPs 
(although guidelines make it clear that the service providers 
should inform their parents and the local child protection 
agency). Likewise, community-based pharmacological 
interventions such as OST are now available for young 
people in the UK and have been developed to recognise the 
different context of working with young people.31
As in other regions, stigma, marginalisation and law 
enforcement practices were reported as significant barriers 
to HIV prevention, care and treatment for young people who 
use illegal drugs. This included a reluctance from young PWID 
to carry syringes due to social stigma, and who often adopt 
dangerous drug storage and concealment methods for fear 
of consequences of police action. Increasing incarceration of 
young people who inject drugs is also a major public health 
challenge, as access to harm reduction measures is usually 
limited or non-existent and HIV/Hepatitis C risk behaviours 
are more prevalent in prison settings.32
Oceania
In Australia, government support for harm reduction service 
provision and scale-up, and debates on drug policy reform, 
have become increasingly challenging. In most cases there 
are no age, gender-based or other criteria that restrict access 
to NSPs in Australia, although the only operational drug 
consumption room (DCR) in the country, which provides 
injecting equipment for use in its service, prohibits access 
to the service for those under the age of 18. Additional 
barriers which can prevent young people accessing services 
in Australia were also reported, including fear of stigma, the 
limited hours of service operation, limited service availability 
outside of major cities and discriminatory attitudes of staff 
towards younger people. While young people under 18 
are not precluded from OST, doctors are discouraged from 
prescribing pharmacotherapies to ‘minors’ in Australia. 
Furthermore, if a ‘child’, that is a person under 18, is accessing 
injecting equipment or OST, staff are required to report this 
to the local child protection agency, which may be a further 
barrier for some young people. 
In New Zealand, the minimum legal age for accessing NSPs 
is 16. Although there is no legal age restriction for OST, for 
those under 18 parental/caregiver support and consent is 
preferred. For those under 16, assessment and consent are 
also needed from an addiction medical specialist and/or a 
child and youth psychiatrist.
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North America
Injecting drug use often starts at a young age in North 
America.33 Age restrictions and limited access to NSPs for 
under-18s represent significant barriers to access to harm 
reduction services in this region. In the USA, although 
restrictions vary by state and by type of treatment setting, 
anyone under 18 must have undergone at least two 
documented attempts at detoxification or outpatient 
psychosocial treatment within 12 months in order to be 
eligible for OST. This inevitably limits the potential for 
young people to access evidence-based harm reduction 
programmes. 
Cost is also likely to be a barrier to treatment in the USA, as 
Medicaid insurance can only be used to pay for MMT in some 
states, and even then it is often time-limited. It was reported 
that private insurance payment is also usually preferred 
by PWID to avoid exposure and stigmatisation, but this is 
unlikely to be an option for young PWID. Additional barriers 
include lengthy waiting lists for methadone clinics in some 
USA regions (particularly in regions far from urban centres), 
regulations around OST programme attendance and regular 
testing for other drug use, all of which are likely to pose 
barriers for young people.
No legal age restrictions for accessing NSPs or OST in Canada 
were reported. Outreach and frontline workers provide 
sterile equipment to young people who show evidence of 
use or need, although many youth in Canada still go without 
services, particularly in rural regions and central/northern 
Canada. 
The TRIP! Project: Youth-Led Harm Reduction in Canada
TRIP! is a youth-led harm reduction project that has been 
providing peer outreach to the dance music community 
in Toronto, Canada for over 15 years. TRIP! aims to include 
young people who use drugs, street-involved and lesbian, 
gay, bisexual, transgender and queer (LGBTQ) youth in direct 
service development and delivery, and to encourage safer 
drug use and safer sex to reduce associated harms including 
the transmission of HIV, Hepatitis C and other sexually 
transmitted infections (STIs). TRIP! does outreach work via 
a variety of venues, including nightclubs, bars, warehouses, 
bridge parties, house parties, street parades and multi-day 
festivals. During outreach events, young people can pick up 
info-cards on dance drugs, routes of administration and safer 
sex, as well as a variety of harm reduction supplies including 
condoms, lubricant, straws, needles and syringes.
In addition to outreach, TRIP! engages youth through social 
networking to circulate messages about safer partying 
practices. Online surveys are employed to monitor patterns 
of drug use, injecting, and ‘high-risk’ behaviours. TRIP! has 
found that youth tend to be most honest when responding 
to anonymous online survey questions. As a result, an annual 
online survey is used to obtain accurate drug use data 
within this community. Information generated by this type 
of youth engagement allows TRIP! to monitor and identify 
emerging health and safety issues, as well as publish alerts 
about dangerous or new substances and laws affecting the 
communities.
While young PWID represent a minority of those with 
whom TRIP! works, injecting is an emerging trend within 
the Toronto community of young people who use drugs. 
The 2010 TRIP! survey found that 9% of young people were 
injecting drugs, with 3% considering doing it in the future. 
Young people who used crystal meth and ketamine were 
more likely to inject, with 17% of meth users and 13% of 
ketamine users reporting injecting. Furthermore, 83% of 
TRIP! youth reported having tried prescription opioids, often 
to deal with the come-down and other side effects reported 
from chronic ketamine use. 
It is important to recognise the value of such projects in 
both increasing young people’s ‘voice’ and also in building 
the existing network of safer nightlife organisations locally, 
nationally and internationally to share information and 
create a peer support network. According to the 2009 
Toronto Teen Survey, many youth distrust health workers, 
instead turning to their friends (53%), siblings, and infolines 
(55%) for health questions.34 
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Increasing young people’s visibility in 
harm reduction
IDU represents a small minority of youth drug use, but it is 
an acute problem affecting those most at-risk young people, 
and it is a much overlooked aspect of the global response to 
injecting-driven HIV epidemics. Young people are excluded 
from harm reduction services in every region of the world. 
Few NSPs or OST programmes target and work with young 
people. This was a recurring theme in the responses to the 
Global State of Harm Reduction 2012 questionnaire. Young 
people face all the same barriers to accessing harm reduction 
services that adults do – limited coverage, stigma and 
criminalisation – and these are further compounded by legal 
age restrictions and other barriers such as a lack of funding 
for youth-focused services. 
At the international-level, the nine core harm reduction 
interventions recommended by the WHO, UNODC and 
UNAIDS35 are not youth-focused, and it appears that 
key issues regarding young people, IDU and HIV may be 
falling between the priority areas of different international 
organisations such as UNAIDS, UNICEF, UNESCO and the 
WHO. Furthermore, while ‘know your epidemic, know your 
response’ has become the rallying cry of UNAIDS,36 when it 
comes to young people and injecting we do not yet ‘know 
our epidemic’. Where surveys do monitor prevalence and 
trends of drug use among young people, they are almost 
always still based on school samples, and PWID remain 
largely invisible in the official statistics on youth drug use.7
This chapter provides a much-needed global snapshot of 
legal age restrictions and other barriers to harm reduction 
services for young people. However, this picture is 
incomplete, and improved data collection should also be 
an international priority, as should significantly increased 
investment in youth-focused harm reduction. This review 
of harm reduction services for young people suggests the 
following priority areas:
Avoid legal age restrictions: Removing the 
barriers caused by legal age restrictions should be a priority, 
especially where the age of initiation to IDU is decreasing. 
Removing such restrictions is an important first step towards 
developing youth-focused services because, although 
OST provision for young people may raise specific medical 
concerns and abstinence-based treatments may be more 
appropriate in some cases, an age restriction on these harm 
reduction services will likely also mean there is nowhere else 
to go.
Youth-led, youth-friendly harm reduction: 
Young people may not identify with more adult-orientated 
models of treatment and should be involved in designing 
new services to meet their specific developmental needs. Our 
case studies highlight how it is possible to use participatory 
and peer-led methods to engage young PWID to inform 
more appropriate youth-led and youth-friendly services. 
International guidelines for OST (for those using opiates) and 
NSPs for children and young people are also required, as are 
clear child protection protocols and rapidly applicable legal 
tests for capacity to consent to treatment and to receive 
treatment without parental consent.
Improving data collection: Street-based surveys 
of young people should be more widely implemented to 
complement existing monitoring systems (e.g. school-based 
surveys), alongside rapid assessments of youth injecting and 
its adverse health outcomes. Furthermore, it is important that 
data on epidemiology and service coverage among PWID be 
disaggregated by age. To this end, existing recommendations 
by UNAIDS, WHO and other multilateral agencies to improve 
country-level data collection via age disaggregation are 
particularly relevant.35,37   Removing legal age restrictions 
may also allow for an improved understanding of patterns of 
injecting through the collection of age-disaggregated client 
data.
Investment in young people most at risk: It is 
imperative that there is sufficient funding and training to 
support new responses focused specifically on the special 
needs of young people at highest risk from drug use. UNAIDS 
has already identified that this is a major problem in Asia, 
where 90% of the resources for young people are spent on 
low-risk youth, who represent just 5% of those who go on to 
become infected with HIV.
Structural interventions – the holistic 
approach: Social policies and interventions which address 
the broader ‘risk environment’ – for example, by addressing 
poverty, trauma, homelessness and social exclusion – are also 
needed and may have the greatest impact on reducing drug-
related harms at a population level.38 This is also in line with 
a children’s rights-based approach.39 Harm reduction in this 
context is about keeping at-risk youth alive and safe, while 
also addressing the causes of their vulnerability.
Finally, we would also emphasise that context is key: what 
works in the United Kingdom and Canada, where child 
protection services are strong, may not work in Nepal or 
the Ukraine. Irrespective of context, however, failing to find 
solutions represents a missed opportunity to protect and 
improve the health of the next generation of young people 
across the world. To do so, further questions must be asked 
about what information is already available, and where 
further investigation is required about IDU among young 
people and about the most appropriate responses to reduce 
drug-related harm among this population. 
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